ASH Joins Medical Groups in Expressing Concern Over Immigration Executive Order
President Donald Trump’s executive order of January 27, which suspended “issuance of visas and other immigration benefits” to nationals of seven Muslim-majority countries, spurred a vigorous national debate and drew a swift response from scientific and medical specialty organizations.
On February 1, the American Society of Hematology (ASH) – along with six other hematology and oncology societies – issued a statement (hematology.org/Newsroom/Press-Releases/2017/7076.aspx) expressing “deep concern” about this executive order and urged the Administration to consider the negative impact it will have on the nation’s ability to attract the world’s best scientific and clinical talent.
In addition, as a member of the Council of Medical Specialty Societies (CMSS), ASH joined more than 30 other groups in supporting the CMSS Position on International Collaboration in Medicine (cmss.org/new/cmss-position-on-international-collaboration-in-medicine).
ASH also joined more than 50 medical groups in signing on to the Association of American Medical Colleges’ February 1 letter to President Trump and was one of a dozen signatories to the American College of Physicians’ February 8 letter to Secretary of Homeland Security the Hon. John F. Kelly on this same issue. Both letters can be found in the “Testimony and Correspondence” section of ASH’s website (hematology.org/Advocacy/Testimony.aspx).
Announcing ASH-AMFDP Award Recipients
ASH has selected Justin Taylor, MD, from Memorial Sloan Kettering Cancer Center, and Roger Belizaire, MD, PhD, from Brigham and Women’s Hospital, to participate in the ASH-Harold Amos Medical Faculty Development Program (ASH-AMFDP).
Designed to increase the number of underrepresented minority scholars in the field of hematology with academic and research appointments, the ASH AMFDP is a component of the ASH Minority Recruitment Initiative, which is supported by the ASH Foundation. The ASH-AMFDP provides four-year research awards, including an annual stipend of up to $75,000 and an annual research grant of $30,000, for a total of $420,000 over the course of the program. Drs. Taylor and Belizaire will spend at least 70 percent of their ASH-AMFDP-funded research under the mentorship of senior faculty at their respective institutions.
Both awardees will study biological and mechanistic effects of genetic mutations that could potentially be harnessed as therapeutic targets for hematologic malignancies. They will begin their projects in July 2017.
Application Process Open for Visitor Training Program
The Visitor Training Program (VTP) provides funding for hematologists or hematology-related health-care professionals in the developing world to receive training on a specific topic or technique for up to 12 weeks. Training is carried out in the clinic or laboratory of an ASH member under his or her supervision and mentorship.
According to Lekidelu Taddesse-Heath, MD, from Howard University, who mentored past awardee John Kuadzi, MD, from the University of Ghana, the benefits of the program are far-reaching. Dr. Kuadzi spent seven weeks training with Dr. Taddesse-Heath, gaining knowledge on how to perform and interpret peripheral smears and bone marrow aspirates, which he used to develop a curriculum to train students at his own institution. Of the experience, Dr. Taddesse-Heath remarked:
“I have witnessed the remarkable educational value of the VTP program and the great potential for hematology capacity building in developing countries. I personally found the program very rewarding. I highly recommend it for those who are considering serving as a host.”
Visit hematology.org/Awards/Career-Training/436.aspx for application information. Mentors are also encouraged to apply. The application deadline is April 10, 2017.
Deadline Approaching for ASH Program for Hematologists in Latin America
The Latin American Training Program (LATP) is accepting applications until March 10, 2017. LATP provides funding for hematologists or hematology-related health-care professionals in Latin America to receive up to 12 weeks of training in one of the following areas:
- Flow Cytometry and Molecular Biology
Faculdade de Medicina de Ribeirão Preto, Brazil
- Adult Stem Cell Transplantation
Hospital Maciel in Montevideo, Uruguay
- Diagnosis and Treatment of Coagulopathies
Instituto Estadual de Hematologia (HEMORIO) in Rio de Janeiro, Brazil
- Thrombosis and Hemostasis
Pontificia Universidad Catolica de Chile in Santiago, Chile
- Pediatric Stem Cell Transplantation (Chile)
Hospital Dr. Luis Calvo Mackenna in Santiago, Chile
- Pediatric Stem Cell Transplantation (Mexico)
National Institute of Pediatrics Mexico DF, Mexico
Upon completion of the training, participants return to their home institutions to implement the skills and knowledge they have learned, ultimately helping advance hematology patient care across the region.
Visit hematology.org/Awards/Career-Training/3061.aspx for application information.